The Potential of Antibody Technology and Silver Nanoparticles for Enhancing Photodynamic Therapy for Melanoma

Keyphrases

• Antibody Technology 100%
• Monoclonal Antibody 100%
• Benzylguanine 66%
• SNAP-tag 66%
• Drug Accumulation 66%
• Antibody-drug Conjugate 66%
• Modified Substrate 33%
• Fusion Protein 33%
• Drug Biodistribution 33%
• Protein Labeling 33%
• Apoptotic Signal 33%
• Resection 33%
• Recombinant Antibody Fragments 33%
• Cancer Heterogeneity 33%
• Site-directed 33%
• DNA Repair Enzymes 33%
• Labeling Scheme 33%
• Disease Stage 33%
• Antibody Fragment 33%
• Melanoma Management 33%
• Antibody Conjugate 33%
• Human DNA 33%
• Autocatalytic 33%
• Biorecognition 33%
• O6-methylguanine-DNA Methyltransferase 33%
• Local Control 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Photodynamic Therapy 100%
• Silver Nanoparticle 100%
• Melanoma 100%
• Monoclonal Antibody 60%
• Nanoparticle 20%
• Malignant Neoplasm 20%
• Biodistribution 20%
• Disease 20%
• Recurrent Disease 20%
• Metastatic Melanoma 20%
• 6 O Alkylguanine DNA Alkyltransferase 20%
• DNA Ligase 20%
• Fusion Protein 20%
• Recombinant Antibody 20%